Abiopharma

New Form 8-K - EPAM Systems, Inc. Filed: 2025-06-26 AccNo: 0001140361-25-023813 Size: 287 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

New Form 144 - DEXCOM INC Filed: 2025-06-26 AccNo: 0001950047-25-004626 Size: 6 KB

New Form 144 - Nuvalent, Inc. Filed: 2025-06-26 AccNo: 0001968582-25-000533 Size: 6 KB

New Form 6-K - SciSparc Ltd. Filed: 2025-06-26 AccNo: 0001213900-25-058382 Size: 360 KB

New Form 424B5 - Lyra Therapeutics, Inc. Filed: 2025-06-26 AccNo: 0001193125-25-148886 Size: 14 KB

New Form 4 - Sage Therapeutics, Inc. Filed: 2025-06-26 AccNo: 0001562180-25-005086 Size: 7 KB

New Form 4 - Sage Therapeutics, Inc. Filed: 2025-06-26 AccNo: 0001562180-25-005087 Size: 7 KB

New Form 8-K - Edgewise Therapeutics, Inc. Filed: 2025-06-26 AccNo: 0001104659-25-063028 Size: 485 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - SCYNEXIS INC Filed: 2025-06-26 AccNo: 0000950170-25-090374 Size: 149 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form 8-K - Elanco Animal Health Inc Filed: 2025-06-26 AccNo: 0001104659-25-063027 Size: 315 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits